BOTHELL, Wash., April 30, 2024 /PRNewswire/ -- BioLife Solutions,
Inc. (NASDAQ: BLFS), a leading supplier of class-defining
bioproduction tools and services for the cell and gene therapies
("CGT") and broader biopharma markets, today announced the
Company's first quarter 2024 financial results will be released
after market close on Thursday, May 9,
2024. The Company will host a conference call and live
webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an
overview of the Company's financial results and give a general
business update.
To access the webcast, log onto the Investor Relations page of
the BioLife Solutions website
at https://www.biolifesolutions.com/earnings. In addition, the
conference call will be accessible by dialing toll-free
1-877-346-6112 or 1-848-280-6350 for international callers. A
webcast replay will be available approximately two hours after the
call and will be archived
on https://investors.biolifesolutions.com for 90 days.
About BioLife Solutions
BioLife Solutions is a leading
supplier of class-defining bioproduction tools and services for the
cell and gene therapy (CGT) and broader biopharma markets. Our
expertise facilitates the commercialization of new therapies by
supplying solutions that maintain the health and function of
biologic materials during collection, development, storage, and
distribution. For more information, please visit
www.biolifesolutions.com or follow BioLife on LinkedIn and X.
Media & Investor Relations
At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com
Investors
LHA Investor Relations
Jody Cain
(310) 691-7100
jcain@lhai.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-report-first-quarter-2024-financial-results-and-business-update-on-may-9-2024-302132232.html
SOURCE BioLife Solutions, Inc.